Hyperglycemia News and Research

RSS
Hyperglycemia occurs when you have a higher than usual level of glucose in your blood. This can happen shortly after you have eaten a big meal and is not a problem if your glucose level returns to normal. Cells remove glucose from the blood in response toinsulin. If your pancreas doesn't make enough insulin, glucose can't enter the cells and remains in the blood. Blood glucose levels can also get too high if cells areunable to respond to insulin properly (insulinresistance). Without glucose, your cells are unable to make energy and can't function properly.
Positive results from Limerick BioPharma's LIM-0705 Phase 1a trial

Positive results from Limerick BioPharma's LIM-0705 Phase 1a trial

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Investigators use ANNs to recognize risk factors of AD in patients with MCI

Investigators use ANNs to recognize risk factors of AD in patients with MCI

Causal relation between multiple factors and occurrence of neurodegenerative disorders: ANNs help understand better

Causal relation between multiple factors and occurrence of neurodegenerative disorders: ANNs help understand better

Using genetic engineering techniques in pigs, scientists create new model of diabetes

Using genetic engineering techniques in pigs, scientists create new model of diabetes

Over 16% of pregnant women diagnosed with gestational diabetes

Over 16% of pregnant women diagnosed with gestational diabetes

USPTO issues notice of allowance for Vanda Pharmaceuticals' Fanapt long-acting injectable formulation

USPTO issues notice of allowance for Vanda Pharmaceuticals' Fanapt long-acting injectable formulation

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

FDA grants approval for Abbott's antiretroviral medication Norvir

FDA grants approval for Abbott's antiretroviral medication Norvir

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

Treating septic shock patients with intensive insulin therapy does not reduce risk of in-hospital death

Treating septic shock patients with intensive insulin therapy does not reduce risk of in-hospital death

Health Canada approves Novartis' Afinitor to treat patients with mRCC

Health Canada approves Novartis' Afinitor to treat patients with mRCC

JDRF and Animas partner to develop an automated system for better control of type 1 diabetes

JDRF and Animas partner to develop an automated system for better control of type 1 diabetes

FDA yet to review MannKind’s NDA for insulin therapy

FDA yet to review MannKind’s NDA for insulin therapy

MicroCHIPS raises $16.5 million to fund for diabetes and osteoporosis programs

MicroCHIPS raises $16.5 million to fund for diabetes and osteoporosis programs

Biodel submits NDA to FDA for clearance to market VIAject

Biodel submits NDA to FDA for clearance to market VIAject

Initial data from REVLIMID Phase III trial in multiple myeloma patients announced

Initial data from REVLIMID Phase III trial in multiple myeloma patients announced

ZYPREXA RELPREVV approved by FDA

ZYPREXA RELPREVV approved by FDA